StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
123
This month
4
This week
1
This year
18
Today
1
Yesterday
1
Publishing Date
2023 - 11 - 28
2
2023 - 10 - 03
2
2023 - 09 - 11
2
2023 - 08 - 30
2
2023 - 08 - 29
2
2023 - 05 - 31
2
2023 - 05 - 03
2
2023 - 04 - 14
2
2023 - 04 - 13
2
2023 - 04 - 05
1
2023 - 03 - 28
1
2023 - 03 - 17
1
2023 - 03 - 10
2
2023 - 03 - 06
1
2023 - 03 - 03
1
2023 - 03 - 01
1
2023 - 02 - 28
1
2023 - 02 - 24
1
2023 - 02 - 20
1
2023 - 02 - 17
1
2023 - 02 - 09
1
2023 - 02 - 06
1
2023 - 01 - 24
1
2023 - 01 - 23
1
2023 - 01 - 13
1
2023 - 01 - 11
2
2023 - 01 - 06
1
2023 - 01 - 03
1
2022 - 12 - 22
1
2022 - 12 - 16
3
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 12 - 08
1
2022 - 12 - 07
1
2022 - 12 - 06
1
2022 - 12 - 02
1
2022 - 12 - 01
1
2022 - 11 - 23
1
2022 - 11 - 21
1
2022 - 11 - 16
2
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 10 - 26
1
2022 - 10 - 24
1
2022 - 10 - 19
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 09 - 22
1
2022 - 09 - 05
1
2022 - 08 - 29
1
2022 - 08 - 25
2
2022 - 08 - 24
1
2022 - 08 - 15
1
2022 - 08 - 12
1
2022 - 07 - 07
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 04 - 26
1
2022 - 03 - 04
1
2022 - 01 - 21
1
Sector
Communications
6
Consumer durables
1
Consumer non-durables
13
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
633
Manufacturing
65
Mining, quarrying, and oil and gas extraction
1
N/a
123
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Active
1
Agreement
6
Alliances
1
America
9
Announcement
2
Application
8
Approval
7
Approved
1
Audio
1
Authorization
2
Avt02
11
Avt03
2
Avt04
9
Avt05
4
Avt06
2
Biosimilar
32
Biotechnology
1
Business
9
Cancer
1
Candidate
4
Care
2
Chmp
1
Commercialization
4
Conference
10
Europe
3
Expected
3
Eylea
3
Financial
12
First
2
For
2
Global
14
Growth
16
Health
3
Hukyndra
2
Humira
5
Japan
2
License
8
Market
39
Migraine
2
Million
3
N/a
117
Nasdaq
5
Opioid
2
Partnership
4
Pharma
6
Positive
3
Prolia
2
Report
14
Results
15
Simponi
4
Six
2
Stelara
10
Study
10
Teva
5
Therapeutics
7
Therapy
3
Treatment
5
Update
19
Xolair
3
Year
4
Entities
180 life sciences corp.
179
Abb ltd
439
Advantest corp
90
Alvotech lux holdings s.a.s.
92
Arrival
98
Atlas copco ab
117
Atlas lithium corp
311
Aura fat projects acquisition corp
257
Beigene, ltd.
119
Blue world acquisition corp
177
Bouygues sa
83
Brainsway ltd.
112
Byline bancorp, inc.
123
Bynordic acquisition corp
309
Canon inc
151
Cf acquisition corp. vii
333
Cybin inc
141
Daimler ag
79
Dmy technology group, inc. vi
110
Encore energy corp.
100
Esab corp
199
Fat projects acquisition corp
410
Hesai group
83
Honeywell international inc.
206
Ix acquisition corp.
129
Johnson & johnson
114
Kamada ltd.
86
Kenvue inc.
100
Kodiak gas services, inc.
270
Koninklijke philips n.v.
78
Lexaria bioscience corp
85
Lithium corp
396
Liveone inc
93
M3-brigade acquisition iii corp.
115
Mallinckrodt plc
132
Medies
294
Metal sky star acquisition corp
315
Mind medicine inc (sub voting)
118
Mobiv acquisition corp
214
Murphy canyon acquisition corp.
98
Nikola corporation
95
Nyxoah sa
80
Orange
164
Oxbridge acquisition corp.
93
Panasonic corp
651
Pegasus digital mobility acquisition corp.
191
Provention bio, inc.
113
Pyrophyte acquisition corp.
84
Quantum fintech acquisition corp
209
Rcf acquisition corp.
101
Relief therapeutics holding sa
109
Sanofi
196
Sealsq corp
159
Sofi technologies inc
90
Teva pharmaceutical industries ltd
123
Tkb critical technologies 1
234
Transalta corporation
80
Vision sensing acquisition corp.
534
Winvest acquisition corp.
77
Wisekey international holding ag
105
Symbols
ABBV
18
ABT
9
ALB
1
ALPMF
4
ALPMY
4
ALVO
84
AMGN
13
ARMV
1
AVDL
1
AZN
10
AZNCF
10
BAX
6
BHC
5
BIIB
2
BMY
1
CMXHF
6
CPIX
1
CSLLY
6
CTLT
1
ENDP
20
ENDPQ
19
GILD
1
GLAXF
15
GNBT
1
GNBTQ
1
GSK
15
ICLR
1
IGXT
1
IPIX
1
JNJ
21
KMDA
83
LLY
5
MEDE
1
MNK
15
MNKKQ
13
MNKPF
10
MNKTQ
2
MS
4
NBRV
1
NBRVF
1
NVO
5
NVS
22
NVSEF
22
OBSV
1
ORMP
1
PFE
3
PPCB
1
PRGO
2
REGN
1
RLFTF
1
RLFTY
1
SNY
16
SNYNF
16
TAK
2
TEVA
2
TEVJF
123
TMO
1
UCBJF
2
UCBJY
2
VTRS
18
Exchanges
Nasdaq
123
Nyse
58
Crawled Date
2023 - 11 - 28
2
2023 - 10 - 03
2
2023 - 09 - 11
2
2023 - 08 - 30
2
2023 - 08 - 29
2
2023 - 05 - 31
2
2023 - 05 - 03
2
2023 - 04 - 14
2
2023 - 04 - 13
2
2023 - 03 - 28
1
2023 - 03 - 17
1
2023 - 03 - 11
1
2023 - 03 - 10
1
2023 - 03 - 06
1
2023 - 03 - 03
1
2023 - 03 - 01
1
2023 - 02 - 28
1
2023 - 02 - 24
1
2023 - 02 - 20
1
2023 - 02 - 17
1
2023 - 02 - 09
1
2023 - 02 - 06
1
2023 - 01 - 24
1
2023 - 01 - 23
1
2023 - 01 - 13
1
2023 - 01 - 12
1
2023 - 01 - 11
1
2023 - 01 - 06
1
2023 - 01 - 03
1
2022 - 12 - 22
1
2022 - 12 - 16
3
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 12 - 08
1
2022 - 12 - 07
1
2022 - 12 - 06
1
2022 - 12 - 02
2
2022 - 11 - 23
1
2022 - 11 - 21
1
2022 - 11 - 16
2
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 10 - 26
1
2022 - 10 - 24
1
2022 - 10 - 19
1
2022 - 10 - 17
1
2022 - 09 - 26
1
2022 - 09 - 22
1
2022 - 09 - 05
1
2022 - 08 - 29
1
2022 - 08 - 25
2
2022 - 08 - 24
1
2022 - 08 - 15
1
2022 - 08 - 12
1
2022 - 07 - 07
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 04 - 26
1
2022 - 03 - 04
1
2022 - 01 - 21
1
Crawled Time
00:00
4
00:20
1
01:00
4
02:00
3
03:00
3
04:20
1
05:00
3
07:00
2
08:00
10
09:00
25
10:00
16
11:00
4
12:00
6
12:20
1
13:00
7
13:20
1
13:30
1
14:20
1
14:30
1
15:00
1
16:00
5
17:00
3
19:00
3
20:00
6
21:00
7
22:00
2
23:00
2
Source
www.biospace.com
6
www.globenewswire.com
78
www.prnewswire.com
39
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
N::A
entities :
Teva pharmaceutical industries ltd
save search
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published:
2024-04-24
(Crawled : 08:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
0.0%
|
O:
2.16%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
0.0%
|
O:
-1.02%
H:
0.0%
C:
0.0%
avt05
simponi
biosimilar
for
topline
results
study
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published:
2024-04-19
(Crawled : 10:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
3.88%
|
O:
1.16%
H:
7.28%
C:
1.3%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
1.76%
|
O:
1.76%
H:
0.0%
C:
0.0%
humira
biosimilar
approved
for
agreement
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published:
2024-04-16
(Crawled : 21:00)
- globenewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
3.17%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
stelara
fda
biosimilar
approval
teva
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
Published:
2024-04-03
(Crawled : 11:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
17.54%
|
O:
2.98%
H:
0.17%
C:
-0.43%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-6.65%
|
O:
-0.18%
H:
2.16%
C:
0.9%
audio
Alvotech Announces Increase in Number of Own Shares
Published:
2024-03-22
(Crawled : 20:00)
- globenewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
Email alert
Add to watchlist
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
Email alert
Add to watchlist
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published:
2024-03-20
(Crawled : 20:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-12.02%
|
O:
-1.58%
H:
1.87%
C:
0.53%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-3.81%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-4.87%
|
O:
-0.89%
H:
0.0%
C:
0.0%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-11.58%
|
O:
0.68%
H:
0.0%
C:
-1.86%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.18%
|
O:
0.58%
H:
1.2%
C:
0.84%
business
year
update
financial
results
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Published:
2024-03-05
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-17.08%
|
O:
-0.99%
H:
0.75%
C:
-0.13%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-18.52%
|
O:
-6.12%
H:
1.67%
C:
1.17%
year
financial
results
Alvotech Appoints Interim Chief Quality Officer
Published:
2024-02-29
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-12.93%
|
O:
-0.58%
H:
3.04%
C:
3.01%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-17.62%
|
O:
-1.27%
H:
2.97%
C:
2.41%
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Published:
2024-02-26
(Crawled : 10:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-16.41%
|
O:
11.35%
H:
0.84%
C:
-3.25%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-15.61%
|
O:
0.0%
H:
1.6%
C:
-0.49%
million
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Published:
2024-02-24
(Crawled : 04:20)
- globenewswire.com
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
Email alert
Add to watchlist
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
simlandi
first
biosimilar
approval
teva
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
Published:
2024-02-15
(Crawled : 12:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-14.65%
|
O:
0.32%
H:
2.98%
C:
0.32%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.23%
|
O:
-0.19%
H:
1.6%
C:
1.24%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-13.64%
|
O:
1.66%
H:
1.96%
C:
0.49%
avt04
stelara
biosimilar
expected
global
market
Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published:
2024-02-08
(Crawled : 05:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
471.43%
|
O:
-14.29%
H:
16.67%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-6.19%
|
O:
0.82%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
0.61%
|
O:
-1.64%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.24%
|
O:
-0.34%
H:
0.0%
C:
-1.2%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.45%
|
O:
-1.57%
H:
0.26%
C:
-0.47%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-1.86%
|
O:
-0.48%
H:
0.16%
C:
0.0%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
4.16%
|
O:
-0.96%
H:
5.91%
C:
3.74%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-6.02%
|
O:
-1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.19%
|
O:
-2.25%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-7.55%
|
O:
0.38%
H:
0.34%
C:
-0.72%
america
growth
market
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published:
2024-01-29
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
-8.53%
|
O:
2.39%
H:
4.67%
C:
1.67%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-9.58%
|
O:
-1.05%
H:
0.41%
C:
-0.35%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-12.26%
|
O:
-0.11%
H:
0.7%
C:
0.65%
avt03
prolia
biosimilar
positive
results
study
Ibuprofen API Market Records Growth of USD 31.68 million from 2022 to 2027, Major Innovations and Key Vendor Offerings - Technavio
Published:
2024-01-23
(Crawled : 10:00)
- prnewswire.com
MNKPF
|
$17.25
|
n/a
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
million
key
growth
market
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Published:
2024-01-19
(Crawled : 17:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
9.25%
|
O:
6.64%
H:
11.54%
C:
8.1%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-11.73%
|
O:
-0.85%
H:
1.46%
C:
0.69%
avt02
avt04
license
update
Paracetamol Market to grow by USD 791.9 million from 2022 to 2027, North America accounts for 37% of market growth- Technavio
Published:
2024-01-17
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-0.26%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-9.29%
|
O:
-1.83%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
3.41%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.92%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
million
market
STADA and Alvotech Secure Approval for Uzpruvo, Europe’s First Ustekinumab Biosimilar to Stelara
Published:
2024-01-10
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
7.29%
|
O:
-0.72%
H:
1.77%
C:
-1.53%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-13.93%
|
O:
-0.66%
H:
0.71%
C:
0.17%
first
biosimilar
approval
stelara
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)
Published:
2024-01-03
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
|
17.96%
|
O:
1.23%
H:
2.17%
C:
1.57%
KMDA
|
$5.16
1.18%
1.16%
11K
|
Health Technology
|
-15.75%
|
O:
-0.97%
H:
1.53%
C:
0.0%
avt06
eylea
candidate
biosimilar
results
study
Erectile Dysfunction (ED) Drugs Market to grow by USD 1.44 billion from 2023-2028, North America to account for 41% of market growth - Technavio
Published:
2023-12-14
(Crawled : 00:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
300.0%
|
O:
0.0%
H:
110.0%
C:
10.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
9.34%
|
O:
-0.87%
H:
1.07%
C:
-0.29%
america
growth
market
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published:
2023-12-08
(Crawled : 15:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
60.0%
|
O:
-20.0%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
PPCB
|
$0.0011
-41.86%
5.6M
|
Manufacturing
|
-88.7%
|
O:
0.0%
H:
2.61%
C:
-4.35%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-8.07%
|
O:
0.07%
H:
1.1%
C:
0.45%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
active
market
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.